KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to 0.15%.

  • West Pharmaceutical Services' Return on Invested Capital fell 200.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.16% for FY2024, which is 300.0% down from last year.
  • Per West Pharmaceutical Services' latest filing, its Return on Invested Capital stood at 0.15% for Q3 2025, which was down 200.0% from 0.15% recorded in Q2 2025.
  • West Pharmaceutical Services' Return on Invested Capital's 5-year high stood at 0.26% during Q1 2022, with a 5-year trough of 0.15% in Q3 2025.
  • In the last 5 years, West Pharmaceutical Services' Return on Invested Capital had a median value of 0.18% in 2023 and averaged 0.2%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first surged by 900bps in 2021, then crashed by -700bps in 2023.
  • West Pharmaceutical Services' Return on Invested Capital (Quarter) stood at 0.26% in 2021, then decreased by -14bps to 0.22% in 2022, then fell by -17bps to 0.18% in 2023, then dropped by -12bps to 0.16% in 2024, then dropped by -8bps to 0.15% in 2025.
  • Its last three reported values are 0.15% in Q3 2025, 0.15% for Q2 2025, and 0.15% during Q1 2025.